Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox injections in rectus femoris for post-stroke stiff knee gait
NL-OMON39359Phase 3Active, not recruiting
- Sponsor
- Roessingh
- Start
- Aug 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of botulinum toxin type A in hemiplegic gait (2 arms), sponsored by Roessingh. Primary endpoints: Knee flexion during swing phase, Energy cost during walking and 10 more. Started Aug 2011; status: active, not recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
hemiplegic gait
Beyond the preview
Go deeper on NL-OMON39359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39359.